Status:
RECRUITING
Vulnerability and Risk of Neuropathic Pain in Cancer
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Neuropathic Pain
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Successive and repeated therapeutic interventions during cancer management - surgery, chemotherapy, radiotherapy - can all, to varying degrees, generate acute pain, central pain sensitization and chro...
Eligibility Criteria
Inclusion
- Inclusion Criteria Patients:
- Patient over 18 years of age,
- Patient suffering from cancer (breast, gynecological, colorectal, lung) and having to undergo one or more anti-cancer therapeutic procedures (chemotherapy, surgery, hormonal therapy, radiotherapy, targeted therapy, etc.),
- Sufficient cooperation and understanding to comply with the study requirements,
- Agreement to give oral consent for the study,
- Affiliation with the French Social Security system.
- Exclusion Criteria Patients:
- History of cancer and anti-cancer therapy (surgery, chemotherapy, radiotherapy, hormone therapy, targeted therapy, etc.),
- History and/or presence of primary brain tumors (glioblastoma, meningioma, neurofibroma, etc.) ),
- History of neurological disorders (Parkinson's disease, Alzheimer's disease, dementia, epilepsy, moderate to severe head trauma, etc.),
- Medical and/or surgical history judged by the investigator or his representative to be incompatible with the study,
- Subject whose cooperation and understanding do not allow strict compliance with the conditions laid down in the protocol,
- Pregnant or breast-feeding women,
- Beneficiary of a legal protection measure.
- Inclusion Criteria Healthy Volunteers:
- Subject over 18 years of age,
- Subject free of any treatment in the 7 days preceding inclusion, in particular no use of analgesics, or judged by the investigator or his representative to be compatible with the study
- Subject with no history of cancer,
- Subject considered to be in good health by the investigator,
- Sufficient cooperation and understanding to comply with the study requirements,
- Agreement to give oral consent to the study,
- Affiliation with the French Social Security system,
- Exclusion Criteria Healthy Volunteers:
- Subjects with a medical and/or surgical history judged by the investigator or his representative to be incompatible with the trial,
- Subjects whose cooperation and understanding do not allow strict compliance with the conditions laid down in the protocol,
- Pregnant or breast-feeding woman,
- Participating in another clinical trial, or within the exclusion period, or having received a total amount of compensation exceeding 4500 euros over the 12 months preceding the start of the trial,
- Benefiting from a legal protection measure.
Exclusion
Key Trial Info
Start Date :
October 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
625 Patients enrolled
Trial Details
Trial ID
NCT06511674
Start Date
October 28 2024
End Date
June 30 2028
Last Update
December 8 2025
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier d'Ajaccio
Ajaccio, France, 20000
2
Centre de Lutte contre le Cancer - Institut de Cancérologie de l'Ouest
Angers, France, 49100
3
Centre Hospitalier Henri Mondor d'Aurillac
Aurillac, France, 15000
4
Centre de Lutte contre le Cancer - Institut Bergonié
Bordeaux, France, 33000